- In June 2021, Biocept, Inc., a prominent provider of molecular diagnostic assays, products, and services, entered into a strategic partnership with Quest Diagnostics to provide laboratory testing services for its Target Selector NGS-based liquid biopsy targeted lung cancer panel to Quest's patient base. This collaboration highlights the growing adoption of advanced biopsy technologies, such as liquid biopsy, in the diagnosis and monitoring of cancer
- In April 2024, Single Pass received FDA clearance for its Kronos biopsy closure device, a class II medical device. This development marks an important advancement in biopsy procedure safety and efficiency. The Kronos biopsy closure device offers enhanced closure capabilities, ensuring better patient outcomes and reducing complications associated with biopsy procedures
- In May 2023, Argon Medical Devices launched the SuperCore Advantage semi-automatic biopsy instrument, a soft tissue biopsy product, in the U.S. market. This launch is a notable addition to the global biopsy devices market, as it introduces an innovative tool designed to enhance the efficiency and precision of soft tissue biopsies
- In February 2023, TransMed7 revealed its plans to launch its U.S.-guided biopsy devices. This announcement is significant for the global biopsy devices market, as it marks the introduction of advanced biopsy solutions designed to enhance precision and accuracy in diagnostic procedures. The launch of U.S.-guided biopsy devices aligns with the growing demand for more effective, minimally invasive tools in biopsy procedures. This innovation is expected to contribute to the expansion of the market by offering healthcare providers new, cutting-edge technologies that improve procedural outcomes and patient care
- In May 2022, Terumo India formed a strategic partnership with Argon Medical to expand their portfolio of medical solutions in the Indian market. By leveraging their combined expertise, the collaboration aims to meet the growing demand for advanced tools in biopsies, deep vein thrombosis treatments, and various other medical procedures. This partnership underscores the increasing demand for innovative diagnostic tools in emerging markets like India. By introducing advanced biopsy technologies to this region, the collaboration is poised to drive growth in the market, addressing the rising need for high-precision, minimally invasive solutions that improve both diagnostic accuracy and patient outcomes
